SCHEMBL6465833

SCHEMBL6465833

NC(=O)Nc1cn(-c2ccc(Cl)cc2)nc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MAPT P10636 4/20 0.53
KDM4E B2RXH2 3/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 2/20 0.53
GAA P10253 2/20 0.53
KMT2A Q03164 2/20 0.53
PKM P14618 1/20 0.53
PARP1 P09874 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP3 Q9Y6F1 1/20 0.48
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
ITK Q08881 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498279 0.92 ALDH1A1 (0.47) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6469788 0.86 KMT2A (0.46) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6466511 0.86 ITK (0.44) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6469794 0.86 LMNA (0.47) ALDH1A1KDM4ENPC1RAB9AKMT2A
SCHEMBL6467527 0.86 KDM4E (0.47) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6498654 0.86 MAPT (0.42) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6499612 0.86 MARS1 (0.44) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6469937 0.85 ITK (0.49) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6468749 0.85 ITK (0.44) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL6497388 0.84 KDM4E (0.53) ALDH1A1MAPTKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALDH1A1 846/4885MAPT 1906/4885KDM4E 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.